# Novavax Inc: Form 8-K, filed Dec 30, 2024

- Company: [Novavax Inc](/companies/nvax.md) (CIK 1000694)
- Form: 8-K
- Filed: 2024-12-30
- Accepted by EDGAR: Dec 30, 2024, 17:27 ET
- Period: 2024-12-30
- Accession: 0001104659-24-132569
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1000694/000110465924132569/tm2432218d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1000694/000110465924132569/

## Items reported

- Item 2.01: Completion of an acquisition or disposition

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1000694/000110465924132569/tm2432218d1_8k.htm

Filed Dec 30, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-132569. Last ingested by Listed: Nov 5, 2026, 12:23 ET. No prices; not investment advice.